Zydus Lifesciences Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ZYDUS LIFESCIENCES, and what generic alternatives to ZYDUS LIFESCIENCES drugs are available?
ZYDUS LIFESCIENCES has eighty-eight approved drugs.
There is one US patent protecting ZYDUS LIFESCIENCES drugs. There is one tentative approval on ZYDUS LIFESCIENCES drugs.
There are four patent family members on ZYDUS LIFESCIENCES drugs in four countries and three hundred and fifteen supplementary protection certificates in sixteen countries.
Summary for Zydus Lifesciences
| International Patents: | 4 |
| US Patents: | 1 |
| Tradenames: | 76 |
| Ingredients: | 75 |
| NDAs: | 88 |
Drugs and US Patents for Zydus Lifesciences
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Zydus Lifesciences | DOXEPIN HYDROCHLORIDE | doxepin hydrochloride | CAPSULE;ORAL | 210700-002 | Mar 23, 2023 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Zydus Lifesciences | CHLORPROMAZINE HYDROCHLORIDE | chlorpromazine hydrochloride | TABLET;ORAL | 213368-004 | Jan 17, 2020 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| Zydus Lifesciences | LOPERAMIDE HYDROCHLORIDE | loperamide hydrochloride | CAPSULE;ORAL | 217471-001 | Mar 23, 2023 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
International Patents for Zydus Lifesciences Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2015128877 | ⤷ Subscribe |
| South Africa | 201606075 | ⤷ Subscribe |
| Philippines | 12016501686 | ⤷ Subscribe |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Zydus Lifesciences Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 0281459 | 98C0036 | France | ⤷ Subscribe | PRODUCT NAME: CLOPIDOGREL HYDROGENE SULFATE; REGISTRATION NO/DATE IN FRANCE: EU/1/98 /069/001 DU 19980715; REGISTRATION NO/DATE AT EEC: DU EU/1-/98/069/001 |
| 2487162 | 132017000002735 | Italy | ⤷ Subscribe | PRODUCT NAME: COBICISTAT O UN SUO SALE FARMACEUTICAMENTE ACCETTABILE O UN SOLVATO DELLO STESSO E DARUNAVIR O UN SUO SALE FARMACEUTICAMENTE ACCETTABILE O UN SOLVATO DELLO STESSO, IN PARTICOLARE DARUNAVIR ETANOLATO(REZOLSTA); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/14/967, 20141121 |
| 1304992 | C300617 | Netherlands | ⤷ Subscribe | PRODUCT NAME: COMBINATIE VAN CLINDAMYCINE, DESGEWENST IN DE VORM VAN CLINDAMYCINEFOSFAAT EN TRETINOINE; NAT. REGISTRATION NO/DATE: RVG 109745 20130626; FIRST REGISTRATION: PA1332/043/001 20130322 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
